title: The IL-15 cytokine system provides growth and survival signals in Hodgkin lymphoma and enhances the inflammatory phenotype of HRS cells.
authors.affiliation: 1] Hematology, Oncology and Tumorimmunology, Max Delbrück Center for Molecular Medicine, Berlin, Germany [2] Hematology, Oncology and Tumorimmunology, Charité, University Hospital Berlin, Campus Virchow Klinikum, Berlin, Germany [3] Freie Universität Berlin, Institute for Chemistry and Biochemistry, Berlin, Germany.
authors.forename: K
authors.initials: K
authors.lastname: Ullrich
authors.affiliation: 1] Hematology, Oncology and Tumorimmunology, Max Delbrück Center for Molecular Medicine, Berlin, Germany [2] Hematology, Oncology and Tumorimmunology, Charité, University Hospital Berlin, Campus Virchow Klinikum, Berlin, Germany.
authors.forename: F
authors.initials: F
authors.lastname: Blumenthal-Barby
authors.affiliation: 1] Hematology, Oncology and Tumorimmunology, Max Delbrück Center for Molecular Medicine, Berlin, Germany [2] Hematology, Oncology and Tumorimmunology, Charité, University Hospital Berlin, Campus Virchow Klinikum, Berlin, Germany.
authors.forename: B
authors.initials: B
authors.lastname: Lamprecht
authors.affiliation: 1] Hematology, Oncology and Tumorimmunology, Max Delbrück Center for Molecular Medicine, Berlin, Germany [2] Hematology, Oncology and Tumorimmunology, Charité, University Hospital Berlin, Campus Virchow Klinikum, Berlin, Germany.
authors.forename: K
authors.initials: K
authors.lastname: Köchert
authors.affiliation: Institute of Pathology, Charité, University Hospital Berlin, Campus Benjamin Franklin, Berlin, Germany.
authors.forename: D
authors.initials: D
authors.lastname: Lenze
authors.affiliation: Institute of Pathology, Charité, University Hospital Berlin, Campus Benjamin Franklin, Berlin, Germany.
authors.forename: M
authors.initials: M
authors.lastname: Hummel
authors.affiliation: 1] Hematology, Oncology and Tumorimmunology, Max Delbrück Center for Molecular Medicine, Berlin, Germany [2] Hematology, Oncology and Tumorimmunology, Charité, University Hospital Berlin, Campus Virchow Klinikum, Berlin, Germany.
authors.forename: S
authors.initials: S
authors.lastname: Mathas
authors.affiliation: 1] Hematology, Oncology and Tumorimmunology, Max Delbrück Center for Molecular Medicine, Berlin, Germany [2] Hematology, Oncology and Tumorimmunology, Charité, University Hospital Berlin, Campus Virchow Klinikum, Berlin, Germany.
authors.forename: B
authors.initials: B
authors.lastname: Dörken
authors.affiliation: 1] Hematology, Oncology and Tumorimmunology, Max Delbrück Center for Molecular Medicine, Berlin, Germany [2] Hematology, Oncology and Tumorimmunology, Charité, University Hospital Berlin, Campus Virchow Klinikum, Berlin, Germany.
authors.forename: M
authors.initials: M
authors.lastname: Janz
mesh_terms: D045744:Cell Line, Tumor; D049109:Cell Proliferation; D015972:Gene Expression Regulation, Neoplastic; D006689:Hodgkin Disease / Q000378:metabolism* / Q000401:mortality; D006801:Humans; D007249:Inflammation; D019409:Interleukin-15 / Q000378:metabolism*; D007694:Killer Cells, Natural / Q000166:cytology; D020935:MAP Kinase Signaling System; D010641:Phenotype; D053647:Receptors, Interleukin-15 / Q000378:metabolism; D016539:Reed-Sternberg Cells / Q000378:metabolism*; D015398:Signal Transduction; D016896:Treatment Outcome
chemical_list: C569274:IL15 protein, human; D019409:Interleukin-15; D053647:Receptors, Interleukin-15